Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

358 ARTÍCULOS , VIENDO DEL 271 AL 285

Bapineuzumab for mild to moderate Alzheimer's disease in two global, randomized, phase 3 trials

Vandenberghe R, Rinne JO, Boada M, Katayama S, Scheltens P, Vellas B, Tuchman M, Gass A, Fiebach JB, Hill D, Lobello K, Li D, McRae T, Lucas P, Evans I, Booth K, Luscan G, Wyman BT, Hua L, Yang L, Brashear HR, Black RS; Bapineuzumab 3000 and 3001 Clinical Study Investigators.

Alzheimers Res Ther. 2016 May 12;8(1):18. doi: 10.1186/s13195-016-0189-7.

The effect of APOE genotype on the delivery of DHA to cerebrospinal fluid in Alzheimer's disease

Yassine HN, Rawat V, Mack WJ, Quinn JF, Yurko-Mauro K, Bailey-Hall E, Aisen PS, Chui HC, Schneider LS.

Alzheimers Res Ther. 2016 Jun 30;8:25. doi: 10.1186/s13195-016-0194-x.

The Need for Early Detection and Treatment in Alzheimer's Disease

EBioMedicine. 2016 Jul;9:1-2. doi: 10.1016/j.ebiom.2016.07.001. Epub 2016 Jul 5.

European multicentre double-blind placebo-controlled trial of Nilvadipine in mild-to-moderate Alzheimer's disease-the substudy protocols: NILVAD frailty; NILVAD blood and genetic biomarkers; NILVAD cerebrospinal fluid biomarkers; NILVAD cerebral blood flow

Meulenbroek O, O'Dwyer S, de Jong D, van Spijker G, Kennelly S, Cregg F, Olde Rikkert M, Abdullah L, Wallin A, Walsh C, Coen R, Kenny RA, Daly L, Segurado R, Borjesson-Hanson A, Crawford F, Mullan M, Lucca U, Banzi R, Pasquier F, Breuilh L, Riepe M, Kalman J, Molloy W, Tsolaki M, Howard R, Adams J, Gaynor S, Lawlor B.

BMJ Open. 2016 Jul 19;6(7):e011584. doi: 10.1136/bmjopen-2016-011584.

A Phase IIa Randomized Control Trial of VEL015 (Sodium Selenate) in Mild-Moderate Alzheimer's Disease

Malpas CB, Vivash L, Genc S, Saling MM, Desmond P, Steward C, Hicks RJ, Callahan J, Brodtmann A, Collins S, Macfarlane S, Corcoran NM, Hovens CM, Velakoulis D, O'Brien TJ.

J Alzheimers Dis. 2016 Jul 22;54(1):223-32. doi: 10.3233/JAD-160544.

Stimulating the Activity of Amyloid-Beta Degrading Enzymes: A Novel Approach for the Therapeutic Manipulation of Amyloid-Beta Levels

Kuruppu S, Rajapakse NW, Spicer AJ, Parkington HC, Smith AI.

J Alzheimers Dis. 2016 Oct 4;54(3):891-895. doi: 10.3233/JAD-160492.

Inflammation, Antiinflammatory Agents, and Alzheimer's Disease: The Last 22 Years

McGeer PL, Rogers J, McGeer EG.

J Alzheimers Dis. 2016 Oct 4;54(3):853-857. doi: 10.3233/JAD-160488.

A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Safety, Pharmacokinetics, and Biomarker Results of Subcutaneous Bapineuzumab in Patients with mild to moderate Alzheimer's disease

Brody M, Liu E, Di J, Lu M, Margolin RA, Werth JL, Booth K, Shadman A, Brashear HR, Novak G.

J Alzheimers Dis. 2016 Oct 18;54(4):1509-1519. doi: 10.3233/JAD-160369.

Overcoming translational barriers impeding development of Alzheimer's disease modifying therapies

Golde TE.

J Neurochem. 2016 Oct;139 Suppl 2(Suppl 2):224-236. doi: 10.1111/jnc.13583. Epub 2016 May 4.

Beyond immunotherapy: new approaches for disease modifying treatments for early Alzheimer's disease

Ruthirakuhan M, Herrmann N, Suridjan I, Abraham EH, Farber I, Lanctôt KL.

Expert Opin Pharmacother. 2016 Dec;17(18):2417-2429. doi: 10.1080/14656566.2016.1258060. Epub 2016 Nov 22.

Vascular biomarkers to predict response to exercise in Alzheimer's disease: the study protocol

Li D, Thomas R, Tsai MY, Li L, Vock DM, Greimel S, Yu F.

BMJ Open. 2016 Dec 30;6(12):e011054. doi: 10.1136/bmjopen-2016-011054.

Increased libido associated with donepezil treatment: a case report

Segrec N, Zaman R, Pregelj P.

Psychogeriatrics. 2016 Jan;16(1):70-2. doi: 10.1111/psyg.12113. Epub 2015 Mar 3.

Spanish validation of the Person-centered Care Assessment Tool (P-CAT)

Martínez T, Suárez-Álvarez J, Yanguas J, Muñiz J.

Aging Ment Health. 2016;20(5):550-8. doi: 10.1080/13607863.2015.1023768. Epub 2015 Mar 26.

A Comparative Descriptive Study of Characteristics of Early- and Late-Onset Dementia Family Caregivers

Ducharme F, Lachance L, Kergoat MJ, Coulombe R, Antoine P, Pasquier F.

Am J Alzheimers Dis Other Demen. 2016 Feb;31(1):48-56. doi: 10.1177/1533317515578255. Epub 2015 Mar 26.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias